Related Experiment Video
Updated: Jun 27, 2025

Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions
Published on: November 30, 2022
Ibuprofen Lyell's Syndrome In An Eight-Year-Old Child
N R Koffi1, Y Pete1, K C N'Da1
1Service d'Anesthésie Réanimation, Centre Hospitalier Universitaire de Bouaké, Côte d'Ivoire.
Insights
Toxic epidermal necrolysis (Lyell's syndrome) is a severe drug reaction requiring intensive care. Early recognition and management are crucial for patient survival and reducing mortality risks.
Area of Science:
- Dermatology
- Toxicology
- Pediatrics
Background:
- Lyell's syndrome, also known as toxic epidermal necrolysis (TEN), is a rare and severe cutaneous adverse drug reaction.
- TEN presents as extensive skin and mucous membrane detachment, mimicking severe burns.
- Urgent and specialized intensive care management is critical for improving patient outcomes.
Purpose of the Study:
- To report a severe case of Lyell's syndrome in a pediatric patient.
- To highlight the rapid onset of TEN following self-medication with a common anti-inflammatory drug.
- To emphasize the importance of prompt diagnosis and management in pediatric TEN.
Main Methods:
- Case report of an eight-year-old child diagnosed with Lyell's syndrome.
- Review of clinical presentation, drug history, and treatment course.
- Focus on the timeline of symptom onset post-medication.
Main Results:
- The patient developed severe Lyell's syndrome within 24 hours of self-administering ibuprofen.
- The case underscores the potential severity of common anti-inflammatory drugs in susceptible individuals.
- Management required intensive care similar to extensive burn treatment.
Conclusions:
- Lyell's syndrome is a critical medical emergency requiring immediate intervention.
- Self-medication with over-the-counter drugs like ibuprofen can precipitate severe reactions in children.
- Vigilance for drug-induced toxic epidermal necrolysis is essential in pediatric practice.
Abstract:
Lyell's syndrome or toxic epidermal necrolysis (TEN) is a rare but serious drug-like toxiderma. Treated as a recent extensive burn in intensive care, its management must be urgent, and adapted in order to improve the vital prognosis of patients and reduce their mortality. We report a severe case of Lyell's syndrome occurring 24 hours after oral administration of an anti-inflammatory drug (ibuprofen) as a self-medication in an eight-year-old child.
More Related Videos
07:50A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
08:44Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
Related Concept Videos
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Drugs for Treatment of Constipation-Predominant IBS
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Other Disorders of Digestive System
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...